Intestinal Endotoxemia and Beta- Cell Dysfunction in Prediabetics
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-65
SponsorSohag University
About this trial
the goal of this observation study is to learn about association between intestinal endotoxemia and prediabetes lean patients with the aim of prevention of diabetes in those category of patients
Eligibility criteria
Qualifiers
Age: 18-65 years
BMI: 18.5-24.9 kg/m²
ADA prediabetes: FPG 100-125 mg/dL OR 2hPG 140-199 mg/dL OR HbA1c 5.7-6.4%
HOMA-IR <1.5 (key inclusion criterion)
Disqualifiers
- HOMA-IR ≥1.5
BMI ≥25 kg/m²
Diabetes, acute inflammation, GI disorders (Table 1) Group II (Controls): Lean normoglycemic ; age and sex-matched healthy subjects
Trial design
Treatments tested in this trial
- hba1c, lbp, fasting blood sugar, lipogram, fastinf insulin
Treatment groups
120 Participants
are divided into 2 treatment groupsLocations
1Sohag University Sohag Egypt
Sponsors and collaborators
Sohag University
Lead sponsor
Source ClinicalTrials.gov